학술논문

Financial Toxicity among Patients with Breast Cancer during the COVID-19 Pandemic in the United States.
Document Type
Article
Source
Cancers. Jan2024, Vol. 16 Issue 1, p62. 14p.
Subject
*CANCER patient psychology
*TREATMENT effectiveness
*SOCIOECONOMIC factors
*FINANCIAL stress
*DISEASE prevalence
*RESEARCH funding
*ODDS ratio
*COVID-19 pandemic
*BREAST tumors
Language
ISSN
2072-6694
Abstract
Simple Summary: Financial toxicity, defined as the financial distress experienced by patients related to their cancer care, can adversely impact clinical outcomes. Little is known about financial toxicity and associated factors among patients with breast cancer during the COVID-19 pandemic. Our study of 669 patients shows that financial toxicity was prevalent in patients with breast cancer, particularly those with metastatic disease, during COVID-19. Lower income and elevated depression symptom severity were the primary factors associated with greater financial toxicity and socioeconomic stress from COVID-19. Patient financial burden is substantial and must be considered when managing breast cancer. This study reported the prevalence of financial distress (financial toxicity (FT)) and COVID-19-related economic stress in patients with breast cancer (BC). Patients with BC were recruited from the Ciitizen platform, Breastcancer.org, and patient advocacy groups between 30 March and 6 July 2021. FT was assessed with the COmprehensive Score for financial Toxicity (COST) instrument. COVID-19-related economic stress was assessed with the COVID-19 Stress Scale. Among the 669 patients, the mean age was 51.6 years; 9.4% reported a COVID-19 diagnosis. The prevalence rates of mild and moderate/severe FT were 36.8% and 22.4%, respectively. FT was more prevalent in patients with metastatic versus early BC (p < 0.001). The factors associated with FT included income ≤ USD 49,999 (adjusted odds ratio (adj OR) 6.271, p < 0.0001) and USD 50,000–USD 149,999 (adj OR 2.722, p < 0.0001); aged <50 years (adj OR 3.061, p = 0.0012) and 50–64 years (adj OR 3.444, p = 0.0002); living alone (adj OR 1.603, p = 0.0476); and greater depression severity (adj OR 1.155, p < 0.0001). Black patients (adj OR 2.165, p = 0.0133), patients with income ≤ USD 49,999 (adj OR 1.921, p = 0.0432), or greater depression severity (adj OR 1.090, p < 0.0001) were more likely to experience COVID-19-related economic stress. FT was common in patients with BC, particularly metastatic disease, during COVID-19. Multiple factors, especially lower income and greater depression severity were associated with financial difficulties during COVID-19. [ABSTRACT FROM AUTHOR]